Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Adherium Ltd. ( (AU:ADR) ) has shared an announcement.
Adherium Limited has successfully completed the Retail component of its Accelerated Non-Renounceable Entitlement Offer, raising a total of $1.4 million. This funding, combined with the previously raised $3.092 million from the Institutional component, will support the company’s growth strategy, including scaling patient onboarding and enhancing its digital respiratory management solutions. The proceeds will be used for hiring in the US, onboarding customers, recruiting a CEO, and general working capital, positioning Adherium to further its leadership in the digital respiratory health sector.
More about Adherium Ltd.
Adherium Limited operates in the healthcare industry, focusing on digital solutions for respiratory disease management. The company specializes in integrating devices and data to optimize outcomes for patients, healthcare professionals, and payers, with a market focus on remote patient monitoring and respiratory health.
Technical Sentiment Signal: Sell
Current Market Cap: A$10.78M
See more insights into ADR stock on TipRanks’ Stock Analysis page.